(Total Views: 261)
Posted On: 07/13/2017 4:01:49 PM
Post# of 72447
Presentation Slides
https://static1.squarespace.com/static/571535...ul2017.pdf
Innovation Pharmaceuticals Phase 2 PoC Trial for Inflammatory Bowel Disease Achieves Induction of Remission in a Majority of Patients Treated with Brilacidin
http://www.ipharminc.com/press-release/2017/7...brilacidin
https://static1.squarespace.com/static/571535...ul2017.pdf
Innovation Pharmaceuticals Phase 2 PoC Trial for Inflammatory Bowel Disease Achieves Induction of Remission in a Majority of Patients Treated with Brilacidin
http://www.ipharminc.com/press-release/2017/7...brilacidin
(2)
(0)
